ARMISTICE CAPITAL, LLC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 236 filers reported holding BLUEBIRD BIO INC in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q4 2021$23,457,000
-50.3%
2,348,000
-5.0%
0.38%
-52.0%
Q3 2021$47,240,000
-19.5%
2,472,000
+34.6%
0.80%
-23.9%
Q2 2021$58,715,000
-0.8%
1,836,000
-6.5%
1.05%
-22.7%
Q1 2021$59,215,000
+55.9%
1,964,000
+123.7%
1.36%
+5.3%
Q4 2020$37,991,000
-12.0%
878,000
+9.8%
1.29%
-17.5%
Q3 2020$43,160,000
+24.5%
800,000
+40.8%
1.57%
+3.0%
Q2 2020$34,671,000
+16.4%
568,000
-12.3%
1.52%
-17.4%
Q1 2020$29,782,000
+1.0%
648,000
+92.9%
1.84%
+8.3%
Q4 2019$29,484,000
+131.8%
336,000
+236.0%
1.70%
+112.1%
Q2 2019$12,720,000
+18.9%
100,000
+47.1%
0.80%
+36.9%
Q1 2019$10,698,000
-16.7%
68,000
-22.7%
0.59%
-24.0%
Q3 2018$12,848,000
-54.5%
88,000
-51.1%
0.77%
-58.2%
Q2 2018$28,251,000
+175.8%
180,000
+200.0%
1.84%
+135.3%
Q1 2018$10,245,000
+64.3%
60,000
+71.4%
0.78%
+26.0%
Q4 2017$6,234,000
+19.4%
35,000
-7.9%
0.62%
+1.1%
Q3 2017$5,219,000
+77.5%
38,000
+35.7%
0.62%
+64.0%
Q2 2017$2,941,000
+34.8%
28,000
+16.7%
0.38%
-16.9%
Q1 2017$2,182,000
-11.6%
24,000
-40.0%
0.45%
-22.8%
Q4 2016$2,468,000
-40.6%
40,000
-58.3%
0.58%
-63.1%
Q2 2016$4,156,00096,0001.58%
Other shareholders
BLUEBIRD BIO INC shareholders Q2 2021
NameSharesValueWeighting ↓
Monashee Investment Management LLC 125,000$13,131,0005.55%
Cormorant Asset Management, LP 275,000$28,889,0004.79%
Eventide Asset Management 569,700$59,847,0003.73%
Crosspoint Capital Strategies, LLC 28,937$3,040,0002.66%
Casdin Capital, LLC 65,000$6,828,0002.53%
ARK Investment Management 119,683$12,573,0002.45%
RTW INVESTMENTS, LP 104,383$10,965,0002.31%
Taylor Wealth Management Partners 38,368$4,031,0001.82%
First Light Asset Management, LLC 33,780$3,549,0001.19%
Atika Capital Management LLC 25,000$2,627,0000.92%
View complete list of BLUEBIRD BIO INC shareholders